Abstract
This article reviews the main data regarding ticagrelor, prasugrel, and clopidogrel therapy in patients with ST-segment elevation myocardial infarction (STEMI). Additional topics include new evidence regarding the timing of antiplatelet loading, managing antiplatelet therapy in patients undergoing CABG surgery, as well as new strategies for managing atrial fibrillation and concomitant coronary artery disease and acute coronary syndromes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
